Arch Venture Management, LLC Beam Therapeutics Inc. Transaction History
Arch Venture Management, LLC
- $122 Million
- Q1 2025
A detailed history of Arch Venture Management, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Arch Venture Management, LLC holds 4,540,132 shares of BEAM stock, worth $76.4 Million. This represents 72.77% of its overall portfolio holdings.
Number of Shares
4,540,132
Previous 4,540,132
-0.0%
Holding current value
$76.4 Million
Previous $113 Million
21.25%
% of portfolio
72.77%
Previous 70.85%
Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
258Shares Held
93.6MCall Options Held
425KPut Options Held
309K-
Farallon Capital Management LLC San Francisco, CA9.93MShares$167 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.87MShares$149 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.48MShares$143 Million1.79% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$128 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.4.27MShares$71.9 Million1.12% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.18B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...